| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Endocrinology, Vol 130, 861-870, Copyright © 1992 by Endocrine Society
ARTICLES |
ZM Lei and CV Rao
Department of Obstetrics and Gynecology, University of Louisville School of Medicine, Kentucky 40292.
The expression of the 15-lipoxygenase (15-LO) gene in pregnancy human myometria, from messenger RNA (mRNA) to the product of the enzyme reaction, was investigated. In situ hybridization with antisense riboprobe synthesized from human reticulocyte 15-LO complementary DNA has revealed the presence of mRNA in myometrial smooth muscle as well as in myometrial blood vessels. Immunoblot analysis with a polyclonal antibody to recombinant human 15-LO enzyme showed a single 110- kilodalton immunoreactive protein in myometria. Light microscope immunocytochemistry using polyclonal antibodies has demonstrated the presence of immunoreactive 15-LO protein and 15-hydroxyeicosatetraenoic acid (15-HETE), the primary product of the 15-LO pathway. While myometrial blood vessels did not show any obvious change, myometrial smooth muscle showed lower 15-LO mRNA, 15-LO immunoreactive protein, and 15-HETE at term pregnancy and during labor. Immunogold electron microscopy showed the presence of immunoreactive 15-LO in rough endoplasmic reticulum and 15-HETE in myofilaments. Quite unexpectedly, both are also present in nuclear chromatin. In summary, the present study demonstrates for the first time the expression of 15-LO gene in pregnancy human myometria and the mRNA and catalytically active enzyme are lower at term pregnancy and during labor. Quite unexpectedly, catalytically active 15-LO is also present in nuclear chromatin. These findings suggest that 15-LO/15-HETE may have genomic as well as nongenomic actions, both of which may either initiate and/or facilitate the progression of labor in women.
This article has been cited by other articles:
![]() |
U. P.Kelavkar, C. Cohen, H. Kamitani, T. E.Eling, and K. F.Badr Concordant induction of 15-lipoxygenase-1 and mutant p53 expression in human prostate adenocarcinoma: correlation with Gleason staging Carcinogenesis, October 1, 2000; 21(10): 1777 - 1787. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. Shureiqi, D. Chen, J. J. Lee, P. Yang, R. A. Newman, D. E. Brenner, R. Lotan, S. M. Fischer, and S. M. Lippman 15-LOX-1: a Novel Molecular Target of Nonsteroidal Anti-inflammatory Drug-Induced Apoptosis in Colorectal Cancer Cells J Natl Cancer Inst, July 19, 2000; 92(14): 1136 - 1142. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. Shureiqi, K. J. Wojno, J. A. Poore, R. G. Reddy, M. J. Moussalli, S. A. Spindler, J. K. Greenson, D. Normolle, A. A.K. Hasan, T. S. Lawrence, et al. Decreased 13-S-hydroxyoctadecadienoic acid levels and 15-lipoxygenase-1 expression in human colon cancers Carcinogenesis, October 1, 1999; 20(10): 1985 - 1995. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Okuda, R. Sakumoto, Y. Uenoyama, B. Berisha, A. Miyamoto, and D. Schams Tumor Necrosis Factor {alpha} Receptors in Microvascular Endothelial Cells from Bovine Corpus Luteum Biol Reprod, October 1, 1999; 61(4): 1017 - 1022. [Abstract] [Full Text] |
||||
![]() |
S. Glover, T. Bayburt, M. Jonas, E. Chi, and M. H. Gelb Translocation of the 85-kDa Phospholipase A[IMAGE] from Cytosol to the Nuclear Envelope in Rat Basophilic Leukemia Cells Stimulated with Calcium Ionophore or IgE/Antigen J. Biol. Chem., June 23, 1995; 270(25): 15359 - 15367. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Endocrinology | Endocrine Reviews | J. Clin. End. & Metab. |
| Molecular Endocrinology | Recent Prog. Horm. Res. | All Endocrine Journals |